Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Cotara® is an experimental new treatment that links a radioactive isotope (iodine
131) to a targeted monoclonal antibody. This monoclonal antibody is designed to bind tumor
cells and deliver radiation directly to the center of the tumor mass while minimizing effects
on normal tissues. Cotara® thus literally destroys the tumor "from the inside out." This may
be an effective treatment for glioblastoma multiforme, a malignant type of brain cancer.
PURPOSE: This trial is studying the safety and radiation distribution of Cotara® in patients
with recurrent glioblastoma multiforme.